HOCHREIN; Hubertus

Patent Applications and Registrations

Patent applications and USPTO patent grants for HOCHREIN; Hubertus.The latest application filed is for "combination therapy for treating cancer with an antibody and intravenous administration of a recombinant mva".

Company Profile

4.21.23

HOCHREIN; Hubertus - Munich DE
Hochrein; Hubertus - Bavaria DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Therapy for Treating Cancer With an Antibody and Intravenous Administration of a Recombinant MVA App 20220249636 - HOCHREIN; Hubertus ; et al.	2022-08-11
Multivalent recombinant modified vaccinia virus ankara (MVA) vector encoding filovirus immunogens Grant 11,338,030 - Volkmann , et al. May 24, 2	2022-05-24
Combination therapy for treating cancer with an intravenous administration of a recombinant MVA and an antibody Grant 11,273,211 - Hochrein , et al. March 15, 2	2022-03-15
Methods and Compositions for Enhancing Vaccine Immune Responses App 20210299236 - Lauterbach; Henning ; et al.	2021-09-30
Methods and compositions for enhancing vaccine immune responses Grant 10,973,892 - Lauterbach , et al. April 13, 2	2021-04-13
Combination Therapy for Treating Cancer with an Intravenous Administration of a Recombinant MVA and an Antibody App 20200306352 - Hochrein; Hubertus ; et al.	2020-10-01
Recombinant Modified Vaccinia Virus Ankara (MVA) Filovirus Vaccine App 20200268872 - Volkmann; Ariane ; et al.	2020-08-27
Recombinant modified vaccinia virus Ankara (MVA) multivalent filovirus immunogenic compositions and methods of use Grant 10,576,141 - Volkmann , et al.	2020-03-03
Methods and compositions for intra-nasal immunization with recombinant MVA encoding flagellin Grant 10,512,684 - Lauterbach , et al. Dec	2019-12-24
Recombinant Modified Vaccinia Virus Ankara (mva) Filovirus Vaccine App 20170304427 - Volkmann; Ariane ; et al.	2017-10-26
Methods And Compositions For Intra-nasal Immunization With Recombinant Mva Encoding Flagellin App 20170290909 - Lauterbach; Henning ; et al.	2017-10-12
Agonists And Antagonists Of Toll-like Receptor (tlr) 13 App 20170137820 - Kirschning; Carsten ; et al.	2017-05-18
Agonists and antagonists of toll-like receptor (TLR) 13 Grant 9,556,439 - Kirschning , et al. January 31, 2	2017-01-31
Interferon-alpha-producing bone marrow dendritic cells Grant 9,149,515 - O'Keeffe , et al. October 6, 2	2015-10-06
Production of IFN-lambda by conventional dendritic cells Grant 9,090,897 - Hochrein July 28, 2	2015-07-28
Methods And Compositions For Enhancing Vaccine Immune Responses App 20150202272 - Lauterbach; Henning ; et al.	2015-07-23
Immediate protection against pathogens via MVA Grant 8,961,998 - Hochrein , et al. February 24, 2	2015-02-24
Agonists And Antagonists Of Toll-like Receptor (tlr) 13 App 20140377309 - Kirschning; Carsten ; et al.	2014-12-25
Modulation of immune responses by the poxviral K4 protein Grant 8,883,168 - Hausmann , et al. November 11, 2	2014-11-11
Modulation Of Immune Responses By The Poxviral K4 Protein App 20130230553 - Hausmann; Jurgen ; et al.	2013-09-05
Immediate Protection Against Pathogens Via Mva App 20130216572 - HOCHREIN; Hubertus ; et al.	2013-08-22
Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF) Grant 8,445,275 - Hochrein , et al. May 21, 2	2013-05-21
Novel Interferon-alpha-producing Bone Marrow Dendritic Cells App 20130122044 - O'Keeffe; Meredith ; et al.	2013-05-16
Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF) Grant 8,354,275 - Hochrein , et al. January 15, 2	2013-01-15
Production Of Ifn-lambda By Conventional Dendritic Cells And Uses Thereof App 20120258082 - Hochrein; Hubertus	2012-10-11
Immediate protection against pathogens via MVA Grant 8,268,327 - Hochrein , et al. September 18, 2	2012-09-18
Immediate protection against pathogens via MVA Grant 8,268,328 - Hochrein , et al. September 18, 2	2012-09-18
Induction Of Dendritic Cell Development With Macrophage-colony Stimulating Factor (m-csf) App 20120010597 - HOCHREIN; Hubertus ; et al.	2012-01-12
Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF) Grant 8,053,234 - Hochrein , et al. November 8, 2	2011-11-08
Immediate Protection Against Pathogens Via Mva App 20110177114 - Hochrein; Hubertus ; et al.	2011-07-21
Induction Of Dendritic Cell Development With Macrophage-colony Stimulating Factor (m-csf) App 20100167332 - Hochrein; Hubertus ; et al.	2010-07-01
Immediate Protection Against Pathogens Via Mva App 20100129404 - Hochrein; Hubertus ; et al.	2010-05-27
Induction Of Dendritic Cell Development With Macrophage-colony Stimulating Factor (m-csf) Receptor Ligands App 20090148405 - Hochrein; Hubertus ; et al.	2009-06-11
Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF) App 20080267994 - Hochrein; Hubertus ; et al.	2008-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.